Literature DB >> 28917532

Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles.

Ji Young Yhee1, Sangmin Jeon2, Hong Yeol Yoon1, Man Kyu Shim3, Hyewon Ko4, Jiwoong Min5, Jin Hee Na6, Hyeyoun Chang1, Hyounkoo Han1, Jong-Ho Kim3, Minah Suh7, Hyukjin Lee6, Jae Hyung Park8, Kwangmeyung Kim9, Ick Chan Kwon10.   

Abstract

In cancer theranostics, the main strategy of nanoparticle-based targeted delivery system has been understood by enhanced permeability and retention (EPR) effect of macromolecules. Studies on diverse nanoparticles provide a better understanding of different EPR effects depending on their structure, physicochemical properties, and chemical modifications. Recently the tumor microenvironment has been considered as another important factor for determining tumor-targeted delivery of nanoparticles, but the correlation between EPR effects and tumor microenvironment has not yet been fully elucidated. Herein, ectopic subcutaneous tumor models presenting different tumor microenvironments were established by inoculation of SCC7, U87, HT29, PC3, and A549 cancer cell lines into athymic nude mice, respectively. In the five different types of tumor-bearing mice, tumor-targeted delivery of self-assembled glycol chitosan nanoparticles (CNPs) were comparatively evaluated to identify the correlation between the tumor microenvironments and targeted delivery of CNPs. As a result, neovascularization and extents of intratumoral extracellular matrix (ECM) were both important in determining the tumor targeted delivery of CNPs. The EPR effect was maximized in the tumors which include large extent of angiogenic blood vessels and low intratumoral ECM content. This comprehensive study provides substantial evidence that the EPR effects based tumor-targeted delivery of nanoparticles can be different depending on the tumor microenvironment in individual tumors. To overcome current limitations in clinical nanomedicine, the tumor microenvironment of the patients and EPR effects in clinical tumors should also be carefully studied.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Enhanced permeability and retention effects; Glycol chitosan; Nanoparticle; Tumor microenvironment; Tumor-targeted delivery

Mesh:

Substances:

Year:  2017        PMID: 28917532     DOI: 10.1016/j.jconrel.2017.09.015

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Biomaterials to model and measure epithelial cancers.

Authors:  Pranjali Beri; Bibiana F Matte; Laurent Fattet; Daehwan Kim; Jing Yang; Adam J Engler
Journal:  Nat Rev Mater       Date:  2018-09-06       Impact factor: 66.308

Review 2.  Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.

Authors:  Hanhee Cho; Seong Ik Jeon; Cheol-Hee Ahn; Man Kyu Shim; Kwangmeyung Kim
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

Review 3.  Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.

Authors:  Seungho Lim; Jooho Park; Man Kyu Shim; Wooram Um; Hong Yeol Yoon; Ju Hee Ryu; Dong-Kwon Lim; Kwangmeyung Kim
Journal:  Theranostics       Date:  2019-10-16       Impact factor: 11.556

4.  Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy.

Authors:  Wan Su Yun; Man Kyu Shim; Seungho Lim; Sukyung Song; Jinseong Kim; Suah Yang; Hee Sook Hwang; Mi Ra Kim; Hong Yeol Yoon; Dong-Kwon Lim; In-Cheol Sun; Kwangmeyung Kim
Journal:  Nanomaterials (Basel)       Date:  2022-09-28       Impact factor: 5.719

5.  Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.

Authors:  Menghao Shi; Jiulong Zhang; Xiaowei Li; Shuang Pan; Jie Li; Chunrong Yang; Haiyang Hu; Mingxi Qiao; Dawei Chen; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2018-07-18

6.  A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy.

Authors:  Shiwei Niu; Gareth R Williams; Jianrong Wu; Junzi Wu; Xuejing Zhang; Xia Chen; Shude Li; Jianlin Jiao; Li-Min Zhu
Journal:  J Nanobiotechnology       Date:  2019-09-10       Impact factor: 10.435

7.  Tumor-acidity activated surface charge conversion of two-photon fluorescent nanoprobe for enhanced cellular uptake and targeted imaging of intracellular hydrogen peroxide.

Authors:  Lanlan Chen; Shuai Xu; Wei Li; Tianbing Ren; Lin Yuan; Shusheng Zhang; Xiao-Bing Zhang
Journal:  Chem Sci       Date:  2019-08-20       Impact factor: 9.825

Review 8.  Glycol Chitosan: A Water-Soluble Polymer for Cell Imaging and Drug Delivery.

Authors:  Fengming Lin; Hao-Ran Jia; Fu-Gen Wu
Journal:  Molecules       Date:  2019-11-29       Impact factor: 4.411

Review 9.  Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment.

Authors:  Cha Yee Kuen; Mas Jaffri Masarudin
Journal:  Molecules       Date:  2022-01-12       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.